For women diagnosed with breast cancer at age 40 years or younger, the risk for isolated locoregional recurrence (LRR) is relatively low, according to a study published online July 23 in JAMA Surgery.
Laura S. Dominici, M.D., from Brigham and Women’s Hospital in Boston, and colleagues examined the long-term incidence of isolated LRR by molecular subtype in a multicenter prospective cohort study of women diagnosed with breast cancer at 40 years or younger from 2006 to 2016.
The cohort included 1,135 women with stage I through III breast cancer, with a median follow-up of 10.1 years. Age at diagnosis was younger than 30 years, 31 to 35 years, and 36 to 40 years for 12.8%, 28.0%, and 59.2% of patients, respectively. The researchers identified 59 isolated local recurrences and four isolated regional recurrences (5.2% and 0.4%, respectively). The cumulative incidence of LRR at 10.1 years by subtype was 4.4%, 4.7%, 6.1%, 2.2%, and 6.5% for luminal A, luminal B, luminal ERBB2+, ERBB2+, and triple-negative, respectively. The cumulative incidence of LRR at 10.1 years by locoregional treatment type was 6.7%, 6.5%, and 2.4% after breast-conserving therapy, mastectomy without radiation, and mastectomy with radiation, respectively. In a multivariable analysis, mastectomy with radiation was associated with the lowest risk for LRR, but no differences were seen when examined by molecular subtype.
“Reassuringly, in this large contemporary study of women diagnosed with breast cancer at age 40 years and undertreated with modern local and systemic therapy, we observed overall low rates of isolated LRR in long-term follow-up, with no significant differences by local therapy strategy when compared within tumor subtype,” the authors write. “Given the lengthy survivorship period for young women with breast cancer and increased numbers of young women being diagnosed, even longer-term follow-up is critical for understanding future LRR risk in these patients.”
Several authors disclosed ties to the biopharmaceutical industry.
More information:
Laura S. Dominici et al, Long-Term Locoregional Outcomes in a Contemporary Cohort of Young Women With Breast Cancer, JAMA Surgery (2025). DOI: 10.1001/jamasurg.2025.2324
Julie A. Margenthaler, Recurrence Risk in Young Women With Breast Cancer, JAMA Surgery (2025). DOI: 10.1001/jamasurg.2025.2332
Copyright © 2025 HealthDay. All rights reserved.
Citation:
Low rates of isolated locoregional recurrence seen in young women with breast cancer (2025, July 29)
retrieved 29 July 2025
from https://medicalxpress.com/news/2025-07-isolated-locoregional-recurrence-young-women.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
